~30%
Profit from MTO element
Industry 4.0 Assessment in Pharma Yields 10 Digital Solutions
The client is a world leader in the development and manufacture of mainly lactose-based excipients. Production is based on make-to-stock and make-to-order principles however, even though the MTO element (highly manual specified products from a designated site) only makes up a small part of orders, it generates ~30 percent of profit.
Industry: Life Sciences
Our Client
The client is a world leader in the development and manufacture of mainly lactose-based excipients. Production is based on make-to-stock and make-to-order principles however, even though the MTO element (highly manual specified products from a designated site) only makes up a small part of orders, it generates ~30 percent of profit.
The Challenge
The IT landscape is made up of unaligned solutions which cause manual (re-)work and inefficiencies. Currently there are unfulfilled business requirements especially data transparency in in-process-control, electronic batch record and customer portal.
Real Results Achieved Together
EFESO's comprehensive Industry 4.0 assessment identified critical pain points and delivered actionable digital solutions with a clear implementation roadmap.
132
Pain points analyzed
10
Digital solutions elaborated
18
Manual Excel workarounds identified
Transformation Impact
- Analysis of 132 pain points in total
- 18 of which were manual Excel workarounds
- 2,100h of unplanned and micro stops per annum
- Elaboration of 10 digital solutions, addressing analyzed pain points
- IT landscape development
- Business case calculation, evaluation and prioritization
- Roadmap development for implementation
Our Approach
EFESO supported by:
- Carrying out analysis of Fit/gap of processes and tools, IT architecture and Industry 4.0 mapping and Potentials assessment
- Using Use cases and payback for business case development and evaluation
- Road mapping the development of waves and work packages
